Equites Radar

WAT · Waters Corporation

Diagnostics & ResearchUnited StatesAnalyst view: Buy

$374.68

+3.42% last session

End-of-day data · updated 2026-07-28

Mildly bullish3 bullish · 1 bearish technical signals
Consensus: Buy (1.84 from 24 analysts)
To mean target: +10.3%

Market cap

$36B

Enterprise value

$42B

Trailing P/E

47.2

Forward P/E

22.5

Dividend yield

Beta

1.20

Avg volume

1M

Employees

16K

2D change

5D change

-2.93%

10D change

0.60%

30D change

-0.86%

60D change

-3.22%

MTD change

-1.83%

YTD change

-2.27%

Analyst Outlook

Consensus ratingBuy
Recommendation mean (1–5)1.84
Covering analysts24
Mean price target$413.12
Low price target$349.00
Upside to mean target+10.3%

Analyst estimates change daily — follow the shifts on the Estimate Trends page.

Technical Analysis

RSI (14)57.8
50-day MA$364.34
200-day MA$353.45
Price vs 50-day MA+5.4%
Price vs 200-day MA+8.6%
MACD histogram-0.12
Volume vs 3-month avg0.7×
52w low $277.7252w high $412.54

Analyst sentiment over time — WAT

Rec Mean (blue, left — higher = more bullish) vs. price targets (right).

Investment Bank Ratings as of 2026-07-14

Latest call per bank · past 12 months

Goldman Sachs

Buy

$425

+13.4% vs price
▲ raised from $380Maintains · 2026-07-14

Morgan Stanley

Equal-Weight

$390

+4.1% vs price
▲ raised from $350Maintains · 2026-07-09

RBC Capital

Outperform

$435

+16.1% vs price
▲ raised from $0.00Initiates · 2026-07-09

HSBC

Buy

$435

+16.1% vs price
▲ raised from $415Maintains · 2026-06-03

Bank of America

Neutral

$400

+6.8% vs price
▲ raised from $370Maintains · 2026-06-02

Wells Fargo

Equal-Weight

$370

-1.2% vs price
▲ raised from $355Maintains · 2026-05-14

Barclays

Overweight

$425

+13.4% vs price
▲ raised from $400Maintains · 2026-05-07

UBS

Neutral

$375

+0.1% vs price
▲ raised from $330Maintains · 2026-05-06

JP Morgan

Neutral

$345

-7.9% vs price
▲ raised from $330Maintains · 2026-05-06

Deutsche Bank

Hold

$330

-11.9% vs price
▼ cut from $370Maintains · 2026-03-25

Jefferies

Buy

$385

+2.8% vs price
▼ cut from $435Maintains · 2025-08-04

Recent rating actions

DateFirmActionRatingPrice target
2026-07-14Goldman SachsMaintainsBuy$380 $425
2026-07-09Morgan StanleyMaintainsEqual-Weight$350 $390
2026-07-09RBC CapitalInitiatesOutperform$0.00 $435
2026-07-08GuggenheimReiteratesBuy$440
2026-07-06Evercore ISI GroupMaintainsOutperform$380 $410
2026-06-11Piper SandlerInitiatesNeutral$0.00 $400
2026-06-03HSBCMaintainsBuy$415 $435
2026-06-02Bank of AmericaMaintainsNeutral$370 $400

Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.

Signal Summary as of 2026-07-28

  • RSI (14): RSI is 58 — neutral momentum, neither overbought nor oversold.
  • Price vs 50-day MA: Trading 5.4% above the 50-day MA ($364.34).
  • Price vs 200-day MA: Trading 8.6% above the 200-day MA ($353.45).
  • MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
  • MACD (12,26,9): MACD histogram is negative (-0.12) — short-term momentum is fading.
  • 52-week range: Price sits between the 52-week low ($277.72) and high ($412.54).

WAT Price Chart

Loading chart for WAT

Fundamentals

Revenue (TTM)$4.0B
EBITDA$1.0B
Free cash flow-$1.0B
Operating cash flow$0M
Book value / share$155.78
Net debt / EBITDA4.5
WACC11.0%
Revenue growth91.00%
Earnings growth

About Waters Corporation

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and supports products, including chromatography columns, and other consumable products. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer goods, and healthcare products, as well as for life science research; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology, which is used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.

More in Diagnostics & Research

Screen WAT against the full market on the Radar →

Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.